The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand, J. Exp. Med, vol.185, pp.1101-1111, 1997. ,
Plasmacytoid dendritic cells in immunity, Nat. Immunol, vol.5, pp.1219-1226, 2004. ,
Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells, Eur. J. Immunol, vol.31, pp.3388-3393, 2001. ,
Natural type I interferon-producing cells as a link between innate and adaptive immunity, Hum. Immunol, vol.63, pp.1126-1132, 2002. ,
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA, Science, vol.303, pp.1529-1531, 2004. ,
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8, Science, vol.303, pp.1526-1529, 2004. ,
A Toll-like receptor recognizes bacterial DNA, Nature, vol.408, pp.740-745, 2000. ,
IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors, Annu. Rev. Immunol, vol.23, pp.275-306, 2005. ,
Dengue Virus Activates Membrane TRAIL Relocalization and IFN-alpha Production by Human Plasmacytoid Dendritic Cells In Vitro and In Vivo, PLOS Neglected Trop. Dis, vol.7, p.2257, 2013. ,
HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha, Proc. Natl Acad. Sci. USA, vol.104, pp.17453-17458, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00177945
Plasmacytoid dendritic cells express TRAIL and induce CD4 þ T-cell apoptosis in HIV-1 viremic patients, Blood, vol.114, pp.3854-3863, 2009. ,
Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells, J. Clin. Investig, vol.122, pp.575-585, 2012. ,
Type I interferon in systemic lupus erythematosus and other autoimmune diseases, Immunity, vol.25, pp.383-392, 2006. ,
Systemic lupus erythematosus: all roads lead to type I interferons, Curr. Opin. Immunol, vol.18, pp.676-682, 2006. ,
HIV-1 infection and induction of interferon alpha in plasmacytoid dendritic cells, Curr. Opin. HIV AIDS, vol.6, pp.373-378, 2011. ,
Pathogenic potential of interferon alphabeta in acute influenza infection, Nat. Commun, vol.5, p.3864, 2014. ,
Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTORp70S6K pathway, Nat. Immunol, vol.9, pp.1157-1164, 2008. ,
Expression of the markers BDCA-2 and BDCA-4 and production of interferonalpha by plasmacytoid dendritic cells in systemic lupus erythematosus, Arthritis Rheum, vol.48, pp.2524-2532, 2003. ,
Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells, J. Immunol, vol.170, pp.2269-2273, 2003. ,
The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration, J. Investig. Dermatol, vol.131, pp.1668-1676, 2011. ,
Atopic phenotype in children is associated with decreased virus-induced interferon-alpha release, Int. Arch. Allergy Immunol, vol.127, pp.82-88, 2002. ,
CD4 and tumor necrosis factor-related apoptosis ligand (TRAIL) localization in HIV-stimulated plasmacytoid dendritic cells by three-dimensional microscopy, AIDS Res. Hum. Retroviruses, vol.30, pp.1158-1159, 2014. ,
Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge, Am. J. Respir. Crit. Care Med, vol.157, pp.1381-1389, 1998. ,
, PDF ISBN, vol.13, p.978876560557, 2013.
Fluorescent false neurotransmitters visualize dopamine release from individual presynaptic terminals, Science, vol.324, pp.1441-1444, 2009. ,
HIV inhibits CD4 þ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells, Blood, vol.109, pp.3351-3359, 2007. ,
Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells, Blood, vol.115, pp.2177-2185, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00456470
TRAIL protein localization in human primary T cells by 3D microscopy using 3D interactive surface plot: a new method to visualize plasma membrane, J. Immunol. Methods, vol.387, pp.147-156, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00844941
Toxicity of polyamines and their metabolic products, Chem. Res. Toxicol, vol.26, pp.1782-1800, 2013. ,
Discovery and characterization of an endogenous CXCR4 antagonist, Cell Rep, vol.11, pp.737-747, 2015. ,
Orally Bioavailable Isothioureas Block Function of the Chemokine Receptor CXCR4 In Vitro and In Vivo, J. Med. Chem, vol.51, pp.7915-7920, 2008. ,
An NMR and molecular modeling study of the site-specific binding of histamine by heparin, chemically modified heparin, and heparin-derived oligosaccharides, Biochemistry, vol.39, pp.3542-3555, 2000. ,
Binding of histamine and antihistamine to bovine serum albumin by mediation with Cu(II), Science, vol.126, pp.561-562, 1957. ,
CD4 À and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells, Virology, vol.423, pp.152-164, 2012. ,
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor, Nat. Med, vol.4, pp.72-77, 1998. ,
Plasmacytoid dendritic cells in HIV infection: striking a delicate balance, J. Leukoc. Biol, vol.87, pp.609-620, 2010. ,
HIV-1 immunopathogenesis: how good interferon turns bad, Clin. Immunol, vol.123, pp.121-128, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00110852
Immunomodulatory action of spermine and spermidine on NR8383 macrophage line in various culture conditions, Cell Immunol, vol.226, pp.86-94, 2003. ,
Spermine inhibition of monocyte activation and inflammation, Mol. Med, vol.5, pp.595-605, 1999. ,
, J. Allergy Clin. Immunol, vol.121, 2008.
Novel compounds containing multiple guanide groups that bind the HIV coreceptor CXCR4, Antimicrob. Agents Chemother, vol.55, pp.255-263, 2011. ,
Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling, Blood, vol.110, pp.4153-4160, 2007. ,
Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients, Blood, vol.116, pp.4870-4873, 2010. ,
CXCL1 2/SDF-1 and CXCR4, Front. Immunol, vol.6, p.301, 2015. ,
Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin, Proc. Natl Acad. Sci. USA, vol.93, pp.14726-14729, 1996. ,
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus, Nature, vol.465, pp.937-941, 2010. ,
Interferon-alpha stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus, Br. J. Dermatol, vol.165, pp.1118-1123, 2011. ,
Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model, J. Exp. Med, vol.211, pp.1977-1991, 2014. ,
Immune unresponsiveness to secondary heterologous bacterial infection after sepsis induction is TRAIL dependent, J. Immunol, vol.187, pp.2148-2154, 2011. ,
Decoding the complexity of type I interferon to treat persistent viral infections, Trends Microbiol, vol.21, pp.634-640, 2013. ,
Persistent LCMV infection is controlled by blockade of type I interferon signaling, Science, vol.340, pp.207-211, 2013. ,
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections, J. Interferon Cytokine Res, vol.35, pp.252-264, 2015. ,
Type I interferonopathies: mendelian type I interferon up-regulation, Curr. Opin. Immunol, vol.32, pp.7-12, 2015. ,
Dendritic cell dysregulation during HIV-1 infection, Immunol. Rev, vol.254, pp.170-189, 2013. ,
HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration, Virology, vol.343, pp.256-266, 2005. ,
IFN-alpha and TRAIL: a double edge sword in HIV-1 disease?, Exp. Cell Res, vol.318, pp.1260-1268, 2012. ,
Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection, PLOS Pathog, vol.9, p.1003658, 2013. ,
Pathogenic mechanisms of HIV disease, Ann. Rev. Pathol, vol.6, pp.223-248, 2011. ,
Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice, PLOS Pathog, vol.10, p.1004291, 2014. ,
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1, Nat. Med, vol.15, pp.955-959, 2009. ,
Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activation, Clin. Dev. Immunol, vol.2012, p.534929, 2012. ,
Small molecule inhibitors of CXCR4, Theranostics, vol.3, pp.47-75, 2013. ,
An efficient method for gene silencing in human primary plasmacytoid dendritic cells: silencing of the TLR7/IRF-7 pathway as a proof of concept, Sci. Rep, vol.6, p.29891, 2016. ,
Time-resolved FRET binding assay to investigate heterooligomer binding properties: proof of concept with dopamine D1/D3 heterodimer, ACS Chem. Biol, vol.10, pp.466-474, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01950133
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction, Biochem. Pharmacol, vol.22, pp.3099-3108, 1973. ,
A fluorescent ligand-binding alternative using Tag-lite(R) technology, J. Biomol. Screen, vol.15, pp.1248-1259, 2010. ,